Home Applications 022262 Application 022262
Type NDA
Sponsor TEVA BRANDED PHARM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LOSEASONIQUE ETHINYL ESTRADIOL; LEVONORGESTREL TABLET;ORAL 0.02MG,0.1MG;0.01MG,N/A No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022262-001 LOSEASONIQUE ETHINYL ESTRADIOL; LEVONORGESTREL 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022262-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022262-001 7855190 2028-12-05 U-1 2011-03-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022262-001 LOSEASONIQUE 0.02MG,0.1MG;0.01MG,N/A TABLET / ORAL AB 2008-10-24 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 45 observed states.
Observed Orange Book patent history# Patent history page 3 of 3 · 93 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022262-001 7615545 2023-06-15 U-1 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022262-001 7858605 2023-06-23 Drug product 2011-01-28 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022262-001 7855190 2028-12-05 U-1 2011-03-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022262-001 7615545 2023-06-15 U-1 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022262-001 7858605 2023-06-23 Drug product 2011-01-28 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022262-001 7855190 2028-12-05 U-1 2011-03-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022262-001 7615545 2023-06-15 U-1 e64feba35796…2022-09-29 23:25 UTC 2022-09 N022262-001 7858605 2023-06-23 Drug product 2011-01-28 e64feba35796…2022-09-29 23:25 UTC 2022-09 N022262-001 7855190 2028-12-05 U-1 2011-03-29 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022262-001 7615545 2023-06-15 U-1 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022262-001 7858605 2023-06-23 Drug product 2011-01-28 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022262-001 7855190 2028-12-05 U-1 2011-03-29 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022262-001 7855190 2028-12-05 U-1 2011-03-29 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join camrese Lo LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL Teva Pharmaceuticals USA, Inc. 4a48e24c-9280-47fe-b200-9b79a7f6bd96 2024-10-31 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 022262 application number: NDA022262 ndc (product): 0093-6148
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 16 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0093-6148 camrese Lo Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0093-6148 camrese Lo Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0093-6148 camrese Lo Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0093-6148 camrese Lo Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0093-6148 camrese Lo Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 0093-6148 camrese Lo Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Pharmaceuticals USA, Inc. NDA AUTHORIZED GENERIC Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51285-092 LoSeasonique Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Teva Women's Health, Inc. NDA Current 51862-045 Amethia Lo levonorgestrel/ethinyl estradiol and ethinyl estradiol Mayne Pharma Inc. NDA AUTHORIZED GENERIC Current 51862-045 Amethia Lo levonorgestrel/ethinyl estradiol and ethinyl estradiol Mayne Pharma Inc. NDA AUTHORIZED GENERIC Current
Documents# Document, Submission type, Date table Document Submission type Date 73333 SUPPL 2023-01-30 73332 SUPPL 2023-01-30 73319 SUPPL 2023-01-30 73318 SUPPL 2023-01-30 70968 SUPPL 2022-05-04 70941 SUPPL 2022-05-03 49378 SUPPL 2017-08-15 49332 SUPPL 2017-08-10 42472 ORIG 2009-08-27 24268 ORIG 2009-08-27 17164 ORIG 2008-11-07 29488 ORIG 2008-10-31